| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |